SIGA - SIGA Technologies Inc.

Day 1m 10m 60m PreMarket Market AfterHours Gap
8.2 0.17 (2.07%) --- --- 0.0 (0.0%) 0.11 (1.34%) 0.17 (2.06%) -0.01 (-0.11%) -0.01 (-0.11%)

SIGA Technologies Inc is a commercial-stage pharmaceutical company focused on the health security market. The company's main product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by the variola virus. The company derives maximum revenue from United States.

Category: PHARMACEUTICAL PREPARATIONS
Market Period: Closed

Earnings & Ratios

Basic EPS:
0.5
Diluted EPS:
0.49
Basic P/E:
16.74
Diluted P/E:
17.0816
RSI(14) 1m:
0.0
VWAP:
8.37
RVol:
0.4162

Events

Period Kind Movement Occurred At
1m Price increase 1m 8.32 +0.09 (+1.05%) Oct 15 09:32

Related News